Supplementation of omega-3 fatty acids in patients with ankylosing spondylitis

Scandinavian Journal of Rheumatology

Volumn 35, Issue 5, 2006, Pages 359-362

  Sundström, Björn ^a   Stalnacke K ^b   Hagfors, L ^c   Johansson, G ^c  

^a Gallivare Hospital   (Sweden)

^b Kiruna Hospital   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; BATH ANKYLOSING DISEASE ACTIVITY INDEX; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FUNCTIONAL DISEASE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; BLOOD SEDIMENTATION; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; RANDOM ALLOCATION; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 33750158774     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740600844357     Document Type: Article

References (15)

1. Gran JT, Husby G. The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum 1993;22:319-34.
2. Bjelle A, Cedergren B, Dahlqvist SR. HLA B27 in the population of northern Sweden. Scand J Rheumatol 1982;11:23-6.
3. Engstrom-Laurent A LI, Nived O, Sturfelt G. [Rheumatology] in Swedish. Stockholm: Liber Förlag, 1994.
4. Khan MA. Epidemiology of HLA-B27 and arthritis. Clin Rheumatol 1996;1:10-12.
5. Boyer GS, Templin DW, Cornoni-Huntley JC, Everett DF. Prevalence of spondyloarthropathies in Alaskan Eskimos. J Rheumatol 1994;21:2292-7.
6. Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand 1980;208:401-6.
7. Cleland LG, James MJ, Proudman SM. The role of fish oils in the treatment of rheumatoid arthritis. Drugs 2003;63:845-53.
8. Belluzzi A, Boschi S, Brignola C, Munarini A, Cariani G, Miglio F. Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr 2000;71:339-42S.
9. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
10. Waldner A, Cronstedt H, Stenstrom CH. The Swedish version of the Bath ankylosing spondylitis disease activity index. Reliability and validity. Scand J Rheumatol 1999;111:10-16.
11. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
12. Cronstedt H, Waldner A, Stenstrom CH. The Swedish version of the Bath ankylosing spondylitis functional index. Reliability and validity. Scand J Rheumatol 1999;111:1-9.
13. Skoldstam L, Hagfors L, Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Ann Rheum Dis 2003;62:208-14.
14. Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study. Arthritis Rheum 1994;37:824-9.
15. Haag M. Essential fatty acids and the brain. Can J Psychiatry 2003;48:195-203.